A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT07290062 · RECRUITING
Trial details
- NCT number
- NCT07290062
- Sponsor
- Insmed Gene Therapy LLC
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-09
- Primary completion
- 2030-03-31
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.